Literature DB >> 23296303

Adenosine and gastrointestinal inflammation.

Sean P Colgan1, Blair Fennimore, Stefan F Ehrentraut.   

Abstract

Nucleosides such as adenosine (Ado) influence nearly every aspect of physiology and pathophysiology. Extracellular nucleotides liberated at local sites of inflammation are metabolized through regulated phosphohydrolysis by a series of ecto-nucleotidases including ectonucleoside triphosphate diphosphohydrolase-1 (CD39) and ecto-5'-nucleotidase (CD73), found on the surface of a variety of cell types. Once generated, Ado is made available to bind and activate one of four G protein-coupled Ado receptors. Recent in vitro and in vivo studies implicate Ado in a broad array of tissue-protective mechanisms that provide new insight into adenosine actions. Studies in cultured cells and murine tissues have indicated that Ado receptors couple to novel posttranslational protein modifications, including Cullin deneddylation, as a new anti-inflammatory mechanism. Studies in Ado receptor-null mice have been revealing and indicate a particularly important role for the Ado A2B receptor in animal models of intestinal inflammation. Here, we review contributions of Ado to cell and tissue stress responses, with a particular emphasis on the gastrointestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296303      PMCID: PMC3560300          DOI: 10.1007/s00109-012-0990-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  82 in total

1.  Cell biology. Purinergic chemotaxis.

Authors:  Joel Linden
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

2.  ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

Authors:  Yu Chen; Ross Corriden; Yoshiaki Inoue; Linda Yip; Naoyuki Hashiguchi; Annelies Zinkernagel; Victor Nizet; Paul A Insel; Wolfgang G Junger
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

3.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function.

Authors:  Holger K Eltzschig; Tobias Eckle; Alice Mager; Natalie Küper; Christian Karcher; Thomas Weissmüller; Kerstin Boengler; Rainer Schulz; Simon C Robson; Sean P Colgan
Journal:  Circ Res       Date:  2006-10-12       Impact factor: 17.367

5.  Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.

Authors:  Makoto Naganuma; Elizabeth B Wiznerowicz; Courtney M Lappas; Joel Linden; Mark T Worthington; Peter B Ernst
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.

Authors:  Tobias Eckle; Thomas Krahn; Almut Grenz; David Köhler; Michel Mittelbronn; Catherine Ledent; Marlene A Jacobson; Hartmut Osswald; Linda F Thompson; Klaus Unertl; Holger K Eltzschig
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

7.  Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.

Authors:  Sergey Ryzhov; Anna E Goldstein; Italo Biaggioni; Igor Feoktistov
Journal:  Mol Pharmacol       Date:  2006-05-17       Impact factor: 4.436

8.  Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation.

Authors:  Joseph Khoury; Juan C Ibla; Andrew S Neish; Sean P Colgan
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

9.  Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility.

Authors:  S Ehrentraut; S Frede; H Stapel; T Mengden; C Grohé; J Fandrey; R Meyer; G Baumgarten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

10.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

View more
  20 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Intestinal Epithelial Ecto-5'-Nucleotidase (CD73) Regulates Intestinal Colonization and Infection by Nontyphoidal Salmonella.

Authors:  Daniel J Kao; Bejan J Saeedi; David Kitzenberg; Krista M Burney; Evgenia Dobrinskikh; Kayla D Battista; Andrés Vázquez-Torres; Sean P Colgan; Douglas J Kominsky
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 3.  Tissue metabolism and the inflammatory bowel diseases.

Authors:  Jordi M Lanis; Daniel J Kao; Erica E Alexeev; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2017-05-20       Impact factor: 4.599

4.  Gastric Metabolomics Detects Helicobacter pylori Correlated Loss of Numerous Metabolites in Both the Corpus and Antrum.

Authors:  Daniela Keilberg; Nina Steele; Sili Fan; Christina Yang; Yana Zavros; Karen M Ottemann
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

5.  Novel therapeutic concepts for inflammatory bowel disease-from bench to bedside.

Authors:  Viola Neudecker; Sean P Colgan; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-09       Impact factor: 4.599

6.  An in vivo RNAi screen uncovers the role of AdoR signaling and adenosine deaminase in controlling intestinal stem cell activity.

Authors:  Chiwei Xu; Brian Franklin; Hong-Wen Tang; Yannik Regimbald-Dumas; Yanhui Hu; Justine Ramos; Justin A Bosch; Christians Villalta; Xi He; Norbert Perrimon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-18       Impact factor: 11.205

7.  Extracellular adenosine signaling in molecular medicine.

Authors:  Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2013-02       Impact factor: 4.599

8.  The guanosine-adenosine interaction exists in vivo.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2014-07-07       Impact factor: 4.030

Review 9.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

Review 10.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.